{"entity":{"type":"insider","cik":"0001276801","url":"/insider/0001276801","json_url":"/insider/0001276801.json","name":"ESSEX WOODLANDS HEALTH VENTURES FUND VI L P","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":5,"first":"2007-04-12","last":"2009-12-10","span_basis":"filed_date"},"name_variants":[{"name":"ESSEX WOODLANDS HEALTH VENTURES FUND VI L P","source":"filing","n_filings":5,"first_seen":"2007-04-12","last_seen":"2009-12-10"}],"transactions":[{"id":5880118,"accession":"0001181431-09-056034","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-09-056034","line_url":"/filing/0001181431-09-056034#line-2","is_derivative":false,"issuer_cik":"0001107421","issuer_name":"ZIOPHARM ONCOLOGY INC","issuer_ticker":"ZIOP","issuer_name_source":null,"issuer_url":"/issuer/0001107421","owner_cik":"0001276801","owner_name":"ESSEX WOODLANDS HEALTH VENTURES FUND VI L P","owner_url":"/insider/0001276801","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":129000.0,"shares_display":"129,000","price_per_share":3.1,"price_display":"3.10","price_state":"stated","total_value":399900.0,"total_display":"399,900.00","shares_owned_after":2371642.0,"shares_owned_after_display":"2,371,642","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-12-08","filed_date":"2009-12-10","scope":"insider"},{"id":5880116,"accession":"0001181431-09-056034","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-09-056034","line_url":"/filing/0001181431-09-056034#line-1","is_derivative":false,"issuer_cik":"0001107421","issuer_name":"ZIOPHARM ONCOLOGY INC","issuer_ticker":"ZIOP","issuer_name_source":null,"issuer_url":"/issuer/0001107421","owner_cik":"0001276801","owner_name":"ESSEX WOODLANDS HEALTH VENTURES FUND VI L P","owner_url":"/insider/0001276801","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":328766.0,"shares_display":"328,766","price_per_share":1.825,"price_display":"1.82","price_state":"stated","total_value":599997.95,"total_display":"599,997.95","shares_owned_after":2242642.0,"shares_owned_after_display":"2,242,642","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-15","filed_date":"2009-12-10","scope":"insider"},{"id":5860073,"accession":"0001181431-09-038509","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-09-038509","line_url":"/filing/0001181431-09-038509#line-2","is_derivative":false,"issuer_cik":"0000920465","issuer_name":"LA JOLLA PHARMACEUTICAL CO","issuer_ticker":"LJPC","issuer_name_source":null,"issuer_url":"/issuer/0000920465","owner_cik":"0001276801","owner_name":"ESSEX WOODLANDS HEALTH VENTURES FUND VI L P","owner_url":"/insider/0001276801","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":368872.0,"shares_display":"368,872","price_per_share":0.1833,"price_display":"0.18","price_state":"stated","total_value":67614.2376,"total_display":"67,614.24","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-08-06","filed_date":"2009-08-07","scope":"insider"},{"id":5860070,"accession":"0001181431-09-038509","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-09-038509","line_url":"/filing/0001181431-09-038509#line-1","is_derivative":false,"issuer_cik":"0000920465","issuer_name":"LA JOLLA PHARMACEUTICAL CO","issuer_ticker":"LJPC","issuer_name_source":null,"issuer_url":"/issuer/0000920465","owner_cik":"0001276801","owner_name":"ESSEX WOODLANDS HEALTH VENTURES FUND VI L P","owner_url":"/insider/0001276801","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":792942.0,"shares_display":"792,942","price_per_share":0.1872,"price_display":"0.19","price_state":"stated","total_value":148438.7424,"total_display":"148,438.74","shares_owned_after":368872.0,"shares_owned_after_display":"368,872","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-08-05","filed_date":"2009-08-07","scope":"insider"},{"id":5753356,"accession":"0001181431-09-011842","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-09-011842","line_url":"/filing/0001181431-09-011842#line-3","is_derivative":false,"issuer_cik":"0000920465","issuer_name":"LA JOLLA PHARMACEUTICAL CO","issuer_ticker":"LJPC","issuer_name_source":null,"issuer_url":"/issuer/0000920465","owner_cik":"0001276801","owner_name":"ESSEX WOODLANDS HEALTH VENTURES FUND VI L P","owner_url":"/insider/0001276801","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4236586.0,"shares_display":"4,236,586","price_per_share":0.0516,"price_display":"0.05","price_state":"stated","total_value":218607.8376,"total_display":"218,607.84","shares_owned_after":1161812.0,"shares_owned_after_display":"1,161,812","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-02-26","filed_date":"2009-02-26","scope":"insider"},{"id":5753354,"accession":"0001181431-09-011842","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-09-011842","line_url":"/filing/0001181431-09-011842#line-2","is_derivative":false,"issuer_cik":"0000920465","issuer_name":"LA JOLLA PHARMACEUTICAL CO","issuer_ticker":"LJPC","issuer_name_source":null,"issuer_url":"/issuer/0000920465","owner_cik":"0001276801","owner_name":"ESSEX WOODLANDS HEALTH VENTURES FUND VI L P","owner_url":"/insider/0001276801","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2186211.0,"shares_display":"2,186,211","price_per_share":0.0635,"price_display":"0.06","price_state":"stated","total_value":138824.3985,"total_display":"138,824.40","shares_owned_after":5398399.0,"shares_owned_after_display":"5,398,399","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-02-25","filed_date":"2009-02-26","scope":"insider"},{"id":5753352,"accession":"0001181431-09-011842","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-09-011842","line_url":"/filing/0001181431-09-011842#line-1","is_derivative":false,"issuer_cik":"0000920465","issuer_name":"LA JOLLA PHARMACEUTICAL CO","issuer_ticker":"LJPC","issuer_name_source":null,"issuer_url":"/issuer/0000920465","owner_cik":"0001276801","owner_name":"ESSEX WOODLANDS HEALTH VENTURES FUND VI L P","owner_url":"/insider/0001276801","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2164033.0,"shares_display":"2,164,033","price_per_share":0.0739,"price_display":"0.07","price_state":"stated","total_value":159922.0387,"total_display":"159,922.04","shares_owned_after":7584610.0,"shares_owned_after_display":"7,584,610","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-02-24","filed_date":"2009-02-26","scope":"insider"},{"id":3730705,"accession":"0001181431-08-031419","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-08-031419","line_url":"/filing/0001181431-08-031419#line-1","is_derivative":false,"issuer_cik":"0000920465","issuer_name":"LA JOLLA PHARMACEUTICAL CO","issuer_ticker":"LJPC","issuer_name_source":null,"issuer_url":"/issuer/0000920465","owner_cik":"0001276801","owner_name":"ESSEX WOODLANDS HEALTH VENTURES FUND VI L P","owner_url":"/insider/0001276801","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2081977.0,"shares_display":"2,081,977","price_per_share":1.89,"price_display":"1.89","price_state":"stated","total_value":3934936.53,"total_display":"3,934,936.53","shares_owned_after":9748643.0,"shares_owned_after_display":"9,748,643","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-05-12","filed_date":"2008-05-14","scope":"insider"},{"id":7107372,"accession":"0001181431-07-025099","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-07-025099","line_url":"/filing/0001181431-07-025099#line-1","is_derivative":false,"issuer_cik":"0000920465","issuer_name":"LA JOLLA PHARMACEUTICAL CO","issuer_ticker":"LJPC","issuer_name_source":null,"issuer_url":"/issuer/0000920465","owner_cik":"0001276801","owner_name":"ESSEX WOODLANDS HEALTH VENTURES FUND VI L P","owner_url":"/insider/0001276801","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000000.0,"shares_display":"1,000,000","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":6000000.0,"total_display":"6,000,000.00","shares_owned_after":7666666.0,"shares_owned_after_display":"7,666,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-04-04","filed_date":"2007-04-12","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001107421","name":"ZIOPHARM ONCOLOGY INC","url":"/issuer/0001107421","role":"Ten percent owner","n_filings":1,"first_seen":"2009-12-10","last_seen":"2009-12-10"},{"type":"issuer","type_label":"ISSUER","cik":"0000920465","name":"LA JOLLA PHARMACEUTICAL CO","url":"/issuer/0000920465","role":"Ten percent owner","n_filings":4,"first_seen":"2007-04-12","last_seen":"2009-08-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001276801","retrieved_at":"2026-08-21T07:46:20+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}